ACM
BNTX icon

Advisors Capital Management’s BioNTech BNTX Stock Holding History

Advisors Capital Management’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-24,581
Closed -$2.27M – 481
2024
Q1 		$2.27M Buy
24,581
+1,864
+8% +$179K 0.04% 245
2023
Q4 		$2.4M Sell
22,717
-5,079
-18% -$512K 0.05% 239
2023
Q3 		$3.02M Sell
27,796
-1,077
-4% -$119K 0.08% 190
2023
Q2 		$3.12M Buy
28,873
+947
+3% +$107K 0.07% 187
2023
Q1 		$3.48M Sell
27,926
-299
-1% -$41.1K 0.09% 172
2022
Q4 		$4.24M Sell
28,225
-392
-1% -$60.3K 0.12% 163
2022
Q3 		$4.59M Buy
28,617
+290
+1% +$44.3K 0.12% 156
2022
Q2 		$4.22M Buy
28,327
+1,691
+6% +$258K 0.13% 155
2022
Q1 		$4.54M Buy
26,636
+833
+3% +$140K 0.12% 157
2021
Q4 		$6.65M Sell
25,803
-17,216
-40% -$4.72M 0.18% 134
2021
Q3 		$11.7M Buy
43,019
+515
+1% +$164K 0.36% 91
2021
Q2 		$9.52M Sell
42,504
-295
-0.7% -$55.6K 0.3% 105
2021
Q1 		$4.67M Buy
+42,799
New +$4.55M 0.16% 141

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Advisors Capital Management's BNTX Position: Q2 2024 in Review

Advisors Capital Management sold out of BioNTech (BNTX) in Q2 2024, closing a stake of 24,581 shares — an estimated $2.27M sold.

Advisors Capital Management first reported a position in BNTX in Q1 2021 and held it in 13 quarters. The position peaked at $11.7M in Q3 2021. 286 funds tracked by Wall St. Rank hold BNTX as of Q2 2024.

  • Advisors Capital Management reported no remaining BioNTech position as of Q2 2024 after selling out during the quarter.
  • Advisors Capital Management sold 24,581 BioNTech shares in Q2 2024, an estimated $2.27M.
  • Advisors Capital Management first reported a position in BioNTech in Q1 2021 and held it in 13 quarters.
  • Advisors Capital Management's BioNTech position peaked at $11.7M in Q3 2021.
  • 286 funds tracked by Wall St. Rank held BioNTech as of Q2 2024.

Based on Advisors Capital Management's 13F filing for Q2 2024, filed 9 Aug 2024.